Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Kollmeier
    Kollmeier
  2. Yamada
    Yamada
  3. Alektiar
    Alektiar
  4. Zhang
    Zhang
  5. McBride
    McBride
  6. Damato
    Damato
  7. Zaider
    Zaider
  8. Gorovets
    Gorovets
  9. Brennan
    Brennan
  10. Dauer
    Dauer

Groups

  1. GDMT, Radiation Oncology (49)
  2. Gynecology Disease Management Team (49)
  3. Radiation Oncology, Department of (49)
  4. Survivorship Research (41)
  5. Medical Physics (21)
  6. Sloan Kettering Institute Postdocs (17)
  7. Radiotherapy Physics Service (15)
  8. Biostatistics Service (11)
  9. Epidemiology and Biostatistics (11)
  10. Surgery (6)
Search Within
  1. "GDMT, Radiation Oncology"
Formats
  1. Journal Article (43)
  2. Meeting Abstract (5)
  3. Guidelines (1)
Groups
  1. GDMT, Radiation Oncology (49)
  2. Gynecology Disease Management Team (49)
  3. Radiation Oncology, Department of (49)
  4. Survivorship Research (41)
  5. Medical Physics (21)
  6. Sloan Kettering Institute Postdocs (17)

More Groups

People
  1. Marisa Kollmeier (38)
  2. Michael Zelefsky (35)
  3. Gilad Cohen (18)
  4. Xin Pei (16)
  5. Yoshiya Yamada (16)
  6. Kaled Alektiar (11)

More People

Years
  1. 2025 (1)
  2. 2022 (4)
  3. 2021 (4)
  4. 2019 (4)
  5. 2018 (1)
  6. 2017 (8)

More Years

Publications
  1. Brachytherapy (30)
  2. European Urology (6)
  3. Journal of Urology (4)
  4. Journal of the American College of Radiology (4)
  5. Urology (3)
  6. Critical Reviews in Oncology/Hematology (2)

Results (49)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy
    Journal Article

    Yamada, Y.; Kollmeier, M. A.; Pei, X.; Kan, C. C.; Cohen, G. N.; Donat, S. M.; Cox, B. W.; Zelefsky, M. J.
    Brachytherapy (2014)

    Fulltext@MSK | Save
  • A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy
    Journal Article

    Zumsteg, Z. S.; Spratt, D. E.; Pei, I.; Zhang, Z.; Yamada, Y.; Kollmeier, M.; Zelefsky, M. J.
    European Urology (2013)

    Fulltext@MSK | Save
  • Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: Implications for defining postradiotherapy urinary toxicity
    Journal Article

    Ghadjar, P.; Jackson, A.; Spratt, D. E.; Oh, J. H.; Munck Af Rosenschold, P.; Kollmeier, M.; Yorke, E.; Hunt, M.; Deasy, J. O.; Zelefsky, M. J.
    European Urology (2013)

    Fulltext@MSK | Save
  • A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer
    Journal Article

    Spratt, D. E.; Scala, L. M.; Folkert, M.; Voros, L.; Cohen, G. N.; Happersett, L.; Katsoulakis, E.; Zelefsky, M. J.; Kollmeier, M. A.; Yamada, Y.
    Brachytherapy (2013)

    Fulltext@MSK | Save
  • American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy
    Journal Article

    Holloway, C. L.; DeLaney, T. F.; Alektiar, K. M.; Devlin, P. M.; O'Farrell, D. A.; Demanes, D. J.
    Brachytherapy (2013)

    Fulltext@MSK | Save
  • Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer
    Journal Article

    Kotecha, R.; Yamada, Y.; Pei, X.; Kollmeier, M. A.; Cox, B.; Cohen, G. N.; Zaider, M.; Zelefsky, M. J.
    Brachytherapy (2013)

    Fulltext@MSK | Save
  • How to select the optimal therapy for early-stage prostate cancer
    Journal Article

    Kollmeier, M. A.; Zelefsky, M. J.
    Critical Reviews in Oncology/Hematology (2012)

    Fulltext@MSK | Save
  • How to select the optimal therapy for early-stage prostate cancer
    Journal Article

    Kollmeier, M. A.; Zelefsky, M. J.
    Critical Reviews in Oncology/Hematology (2012)

    Fulltext@MSK | Save
  • Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Zelefsky, M. J.; Chou, J. F.; Pei, X.; Yamada, Y.; Kollmeier, M.; Cox, B.; Zhang, Z.; Schechter, M.; Cohen, G. N.; Zaider, M.
    Brachytherapy (2012)

    Fulltext@MSK | Save
  • A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer
    Journal Article

    Kollmeier, M. A.; Pei, X.; Algur, E.; Yamada, Y.; Cox, B. W.; Cohen, G. N.; Zaider, M.; Zelefsky, M. J.
    Brachytherapy (2012)

    Fulltext@MSK | Save